Thyroid · THYROID 90 mg/1 · Tablet · Oral · Oliva Therapeutics, LLC
NDC 82685-0344-01 · 100 TABLET in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Just 3 companies supply this market — thin enough that a single exit would be felt immediately. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
Some pressure is visible, but not much — here’s everything the score found to count.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| ANI Pharmaceuticals, Inc. | THYROID 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ANI Pharmaceuticals, Inc. | THYROID 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ANI Pharmaceuticals, Inc. | THYROID 90 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ANI Pharmaceuticals, Inc. | THYROID 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| ANI Pharmaceuticals, Inc. | THYROID 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Oliva Therapeutics, LLC | THYROID 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Oliva Therapeutics, LLC | THYROID 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Oliva Therapeutics, LLC | THYROID 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Oliva Therapeutics, LLC | THYROID 180 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Oliva Therapeutics, LLC | THYROID 240 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Oliva Therapeutics, LLC | THYROID 300 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Oliva Therapeutics, LLC | THYROID 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Oliva Therapeutics, LLC | THYROID 90 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Vitruvias Therapeutics | THYROID 90 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Vitruvias Therapeutics | THYROID 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Vitruvias Therapeutics | THYROID 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Vitruvias Therapeutics | THYROID 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Vitruvias Therapeutics | THYROID 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Amerithroid — NDC 82685-0344-01," retrieved September 3, 2026, https://drugdashboards.com/drug/82685034401.
Free to cite with attribution — see how the data is put together.